Cpu-86017 Improves the Compromised Blood-Brain Barrier Permeability Mediated by Impaired Endothelial No System and Oxidative Stress Caused by L-Thyroxine

RH Du,DC Cibangu,DZ Dai,S Lin,L Guan

DOI: https://doi.org/10.1002/ddr.10410

2005-01-01

Drug Development Research

Abstract:Impaired endothelial cell (EC) function leads to alterations in the permeability of the blood-brain barrier (BBB). There are two aspects of the transport through the BBB: from the blood to the brain (influx) and from the brain to the blood (efflux). An impaired EC model induced by L-thyroxine that compromises the influx and efflux properties of the BBB was used to assess responses to the intervention of CPU-86017 (an antioxidant and calcium channel blocker) and propranolol. CPU-8601 7 (t(1/2) = 1.5 h) was also used as a target drug, leaving no traces in the brain and blood 24 h after administration. The permeability of the BBB was evaluated by using CPU-8601 7 after iv and icv injection and concentrations in the blood and brain being measured by high-performance liquid chromatography. The bidirectional permeability of CPU-86017 was impaired and associated with a reduced NO bioavailability assessed functionally by the vasoactivity in the model. Partial relief of NO bioavailability and oxidative stress induced by propranolol was consistent with a recovery of BBB efflux alone. Complete recovery in the efflux and influx of the BBB by CPU-8601 7 was a result of the complete restoration of NO bioavailability and reduction in oxidative stress. Normal BBB influx is dependent on an intact endothelial NO system, and efflux could be restored easily by partial improvement of NO bioavailability. CPU-86017 is thus more effective than propranolol in protecting the endothelium from damage produced by L-thyroxine through oxidative stress. (c) 2005 Wiley-Liss, Inc.